{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 cause autosomal recessive PD. PINK1 protects against oxidative-stress-induced cell death by phosphorylating TRAP1 to suppress cytochrome c release.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 kinase activity to TRAP1 phosphorylation and mitochondrial protection, which are disrupted by PD-linked variants."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1's kinase activity and ability to phosphorylate TRAP1 were tested in vitro and in vivo. Cell survival under oxidative stress was assessed.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays and cell survival models directly address PINK1's role in mitochondrial protection, aligning with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study compared wild-type PINK1 with mutant variants (G309D, L347P, W437X) to assess phosphorylation of TRAP1 and cell survival.",
          "judgment": "Yes",
          "reasoning": "Wild-type PINK1 was used as a control, and multiple mutant variants were tested. Replicates are implied by the study's conclusion but not explicitly stated.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic variants (G309D, L347P, W437X) were directly tested for TRAP1 phosphorylation and cell survival.",
          "judgment": "No",
          "reasoning": "No external pathogenic/benign variant controls were used; the study focused on the three PD-linked variants without comparison to other classified variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study reports functional impairment of the variants but does not provide statistical analyses (e.g., p-values, effect sizes) or OddsPath calculations.",
          "judgment": "Yes",
          "reasoning": "The total number of variant controls is three (G309D, L347P, W437X), which is fewer than 10. This limits quantitative strength assessment.",
          "next_step_or_outcome": "Final strength determination"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_reasoning": "The study demonstrates that the G309D variant impairs PINK1's ability to phosphorylate TRAP1 and protect cells from oxidative stress. While the assays are biologically relevant and controls are present, lack of statistical rigor and limited variant controls restrict the evidence to 'supporting' strength."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 cause autosomal recessive PD. PINK1 protects against oxidative-stress-induced cell death by phosphorylating TRAP1 to suppress cytochrome c release.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 kinase activity to TRAP1 phosphorylation and mitochondrial protection, which are disrupted by PD-linked variants."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1's kinase activity and ability to phosphorylate TRAP1 were tested in vitro and in vivo. Cell survival under oxidative stress was assessed.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays and cell survival models directly address PINK1's role in mitochondrial protection, aligning with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study compared wild-type PINK1 with mutant variants (G309D, L347P, W437X) to assess phosphorylation of TRAP1 and cell survival.",
          "judgment": "Yes",
          "reasoning": "Wild-type PINK1 was used as a control, and multiple mutant variants were tested. Replicates are implied by the study's conclusion but not explicitly stated.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic variants (G309D, L347P, W437X) were directly tested for TRAP1 phosphorylation and cell survival.",
          "judgment": "No",
          "reasoning": "No external pathogenic/benign variant controls were used; the study focused on the three PD-linked variants without comparison to other classified variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study reports functional impairment of the variants but does not provide statistical analyses (e.g., p-values, effect sizes) or OddsPath calculations.",
          "judgment": "Yes",
          "reasoning": "The total number of variant controls is three (G309D, L347P, W437X), which is fewer than 10. This limits quantitative strength assessment.",
          "next_step_or_outcome": "Final strength determination"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_reasoning": "The study demonstrates that the L347P variant impairs PINK1's ability to phosphorylate TRAP1 and protect cells from oxidative stress. While the assays are biologically relevant and controls are present, lack of statistical rigor and limited variant controls restrict the evidence to 'supporting' strength."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 cause autosomal recessive PD. PINK1 protects against oxidative-stress-induced cell death by phosphorylating TRAP1 to suppress cytochrome c release.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly links PINK1 kinase activity to TRAP1 phosphorylation and mitochondrial protection, which are disrupted by PD-linked variants."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "PINK1's kinase activity and ability to phosphorylate TRAP1 were tested in vitro and in vivo. Cell survival under oxidative stress was assessed.",
          "judgment": "Yes",
          "reasoning": "Kinase activity assays and cell survival models directly address PINK1's role in mitochondrial protection, aligning with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study compared wild-type PINK1 with mutant variants (G309D, L347P, W437X) to assess phosphorylation of TRAP1 and cell survival.",
          "judgment": "Yes",
          "reasoning": "Wild-type PINK1 was used as a control, and multiple mutant variants were tested. Replicates are implied by the study's conclusion but not explicitly stated.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic variants (G309D, L347P, W437X) were directly tested for TRAP1 phosphorylation and cell survival.",
          "judgment": "No",
          "reasoning": "No external pathogenic/benign variant controls were used; the study focused on the three PD-linked variants without comparison to other classified variants.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study reports functional impairment of the variants but does not provide statistical analyses (e.g., p-values, effect sizes) or OddsPath calculations.",
          "judgment": "Yes",
          "reasoning": "The total number of variant controls is three (G309D, L347P, W437X), which is fewer than 10. This limits quantitative strength assessment.",
          "next_step_or_outcome": "Final strength determination"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_reasoning": "The study demonstrates that the W437X variant impairs PINK1's ability to phosphorylate TRAP1 and protect cells from oxidative stress. While the assays are biologically relevant and controls are present, lack of statistical rigor and limited variant controls restrict the evidence to 'supporting' strength."
    }
  ]
}